Georgia: Emory Snags $6 Million for HIV/AIDS Vaccine Research
September 21, 2012
The Bill & Melinda Gates Foundation has awarded Emory University a $6 million grant as part of the Collaboration for AIDS Vaccine Discovery (CAVD). The Collaboration, an international network of experts and scientists, works on discovering HIV vaccine candidates. Through the grant, the Emory research team, led by Bali Pulendran, will be able to optimize the TLR nanoparticle approach for an HIV vaccine and to test the vaccine. The research involves creating nanoparticles that mimic viruses and are covered with molecules that activate Toll-like receptors (TLRs). The nanoparticles stimulate long-lasting immune responses to inactivated influenza virus when used in mice. The Bill & Melinda Gates Foundation started the CAVD in 2006 and has funded 30 grants supporting investigators in 19 countries.
09.20.2012; Alison Bryant
Bill Gates Stresses Importance of Investment in Both HIV Treatment and Research for Vaccines, Microbicides
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)